Seeing Is Believing
Currently out of the existing stock ratings of Constantine Davides, 111 are a BUY (97.37%), 3 are a HOLD (2.63%).
Analyst Constantine Davides, carries an average stock price target met ratio of 46.76% that have a potential upside of 43.48% achieved within 245 days. Previously, Constantine Davides worked at BARCLAYS, BENCHMARK.
Constantine Davides’s has documented 221 price targets and ratings displayed on 29 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on PGNY, Progyny at 08-Sep-2026.
Analyst best performing recommendations are on ISPC (ISPECIMEN).
The best stock recommendation documented was for ISPC (ISPECIMEN) at 11/23/2021. The price target of $12 was fulfilled within 1 day with a profit of $1.19 (9.02%) receiving and performance score of 90.22.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$1.5
$0.84 (127.27%)
$10
3 years 1 months 1 days ago
(01-Sep-2023)
0/3 (0%)
$0.36 (31.58%)
Buy
$8
$7.34 (1112.12%)
$9
4 years 6 months 25 days ago
(07-Mar-2022)
0/2 (0%)
$5.54 (225.20%)
Buy
$8
$7.34 (1112.12%)
$48
7 years 3 months 7 days ago
(25-Jun-2019)
0/4 (0%)
$3.88 (94.17%)
Which stock is Constantine Davides most bullish on?
Which stock is Constantine Davides most reserved on?